rs1219530033
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_012401.4(PLXNB2):c.5064C>G(p.Phe1688Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000138 in 1,447,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012401.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000829 AC: 2AN: 241276 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1447398Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 717764 show subpopulations
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5064C>G (p.F1688L) alteration is located in exon 33 (coding exon 31) of the PLXNB2 gene. This alteration results from a C to G substitution at nucleotide position 5064, causing the phenylalanine (F) at amino acid position 1688 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at